Genomics Institute of the Novartis Research Foundation (GNF) applies integrated state-of-the-art technologies in chemistry, biology, automation, and information sciences to identify new biological processes and disease-relevant mechanisms and develop new therapeutics in a variety of areas, including cancer biology, cardiovascular/metabolism, immunology, respiratory disease, neuroscience and infectious disease.